WEDNESDAY, July 23, 2025 (HealthDay News) -- Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) are associated with reduced type 2 diabetes mellitus (T2DM)-related dementia risk compared with metformin, according to a study published online July 22 in BMJ Open Diabetes Research & Care.Mingyang Sun, from the People's Hospital of Zhengzhou University in China, and colleagues conducted a retrospective cohort study using data from a global health research network between 2004 and 2024 to examine the comparative effectiveness of GLP-1 RAs and metformin in reducing dementia risk
Delivery methods in research and clinical studies include intra articular injection, intravenous administration, and intravenous infusion
Store B12 injections in a cool, dry place, typically below 77F (25C) and avoid leaving them in hot environments, such as inside a car, near a stove, or in direct sunlight for extended periods
Furthermore, ALC acts as a potent antioxidant, helping to safeguard brain cells from oxidative deteriorationmaking it highly beneficial for targeted memory support and other age-related cognitive applications
The molecule exists in two primary forms: reduced glutathione (GSH), which constitutes more than 98% of total glutathione under normal physiological conditions, and oxidized glutathione (GSSG)
The antioxidant alpha-lipoic acid (ALA) can vanquish free radicals throughout the body
